Freshfields and Wachtell steer AstraZeneca/Alexion

Alex Wilts

15 December 2020

Shutterstock/Ascannio

AstraZeneca has tapped Freshfields Bruckhaus Deringer to guide its $39 billion acquisition of Alexion Pharmaceuticals, which is being advised by Wachtell Lipton Rosen & Katz.

Subscribe to Global Competition Review

Subscribe and start reading now

Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.

Subscribe now

Already have access? Login below

Alex Wilts

View full biography

Author | Editor, GCR USA

[email protected]

Tipline

BCP, phone home: The Tipline for 24 June 2022
Competition is all the rage and the Federal Trade Commission’s bureau of consumer protection wants in on the fun. It's not the right-to-repair antitrust lawsuit you might have been dreaming up, but the commission says Harley Davidson and Westinghouse impeded fair competition by restricting customers from using independent repair shops. Also in Tipline, major appellate attorneys form their own firm and the Department of Justice’s antitrust division brings another fraud case.
Child’s play: The Tipline for 23 June 2022
Legislative solstice: The Tipline for 22 June 2022

Freshfields and Wachtell steer AstraZeneca/Alexion

Subscribe to Global Competition Review

Subscribe and start reading now

Already have access? Login below

Related Topics

Alex Wilts